Expression and function of miR-155 in breast cancer

被引:14
|
作者
Liu, Jing [1 ]
Huang, WenHui [1 ]
Yang, HaiXia [2 ]
Luo, Ying [1 ]
机构
[1] Kunming Univ Sci & Technol, Lab Mol Genet Aging & Tumor, Fac Med, Kunming, Yunnan, Peoples R China
[2] Municipal Author Clin Jinan, Outpatient Dept, Jinan, Shandong, Peoples R China
关键词
miR-155; breast cancer; oncogenic miRNA; target genes; TRANSCRIPTION FACTOR FOXO3A; CLINICAL-SIGNIFICANCE; ABERRANT EXPRESSION; CELL-PROLIFERATION; GENE-EXPRESSION; MICRORNAS; GROWTH; METASTASIS; NETWORKS; PATHWAY;
D O I
10.1080/13102818.2015.1043946
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A major problem in the treatment of breast cancer at present is the lack of more sensitive and specific tumour biomarkers. MicroRNAs (miRNAs) were first discovered as important regulators of development in Caenorhabditis elegans, and their functions have been widely investigated. miR-155 is an oncogenic miRNA which has been explored mainly in leukaemia but is also known to play an important role in the progression of breast cancer. There is an accumulating body of evidence about additional roles of miR-155 in the development of breast cancer. In this mini-review, we provide an overview and update of miR-155 expression and its roles in breast cancer. We also attempt to summarize the current understanding of miR-155 regulation networks and speculate on the potential of miR-155 as a putative accessory parameter for diagnosis of breast cancer.
引用
收藏
页码:840 / 843
页数:4
相关论文
共 50 条
  • [31] miR-155 and miR-122 Expression of Spermatozoa in Obese Subjects
    Lopez, Paulina
    Castro, Andrea
    Florez, Martha
    Miranda, Karen
    Aranda, Pilar
    Sanchez-Gonzalez, Cristina
    Llopis, Juan
    Arredondo, Miguel
    FRONTIERS IN GENETICS, 2018, 9
  • [32] miR-155 and miR-31 are differentially expressed in breast cancer patients and are correlated with the estrogen receptor and progesterone receptor status
    Lu, Zhenduo
    Ye, Yuping
    Jiao, Dechuang
    Qiao, Jianhua
    Cui, Shude
    Liu, Zhenzhen
    ONCOLOGY LETTERS, 2012, 4 (05) : 1027 - 1032
  • [33] Inhibition of miR-155, a therapeutic target for breast cancer, prevented in cancer stem cell formation
    Zuo, Jiangcheng
    Yu, Yalan
    Zhu, Man
    Jing, Wei
    Yu, Mingxia
    Chai, Hongyan
    Liang, Chunzi
    Tu, Jiancheng
    CANCER BIOMARKERS, 2018, 21 (02) : 383 - 392
  • [35] MiR-150 and miR-155 expression predicts survival of cervical cancer patients: a translational approach to novel prognostic biomarkers
    Santos, Joana M. O.
    Tavares, Valeria
    da Costa, Rui M. Gil
    Medeiros, Rui
    BIOMARKERS, 2023, 28 (07) : 617 - 627
  • [36] Increased expression of miR-155 and miR-222 is associated with lymph node positive status
    Chernyy, Vladimir
    Pustylnyak, Vladimir
    Kozlov, Vadim
    Gulyaeva, Lyudmila
    JOURNAL OF CANCER, 2018, 9 (01): : 135 - 140
  • [37] Pro-carcinogenic actions of miR-155/FOXO3a in colorectal cancer development
    Wang, Dianxiu
    Geng, Wei
    Han, Lu
    Song, Ran
    Qu, Qiusi
    Chen, Xingyuan
    Luo, Xi
    CELLULAR AND MOLECULAR BIOLOGY, 2023, 69 (10) : 160 - 165
  • [38] mir-155 expression is downregulated in kidney transplant patients with human cytomegalovirus infection
    Bergallo, Massimiliano
    Gambarino, Stefano
    Montanari, Paola
    Dapra, Valentina
    Rassu, Marco
    Galliano, Ilaria
    Ravanini, Paolo
    TRANSPLANT IMMUNOLOGY, 2017, 43-44 : 60 - 63
  • [39] Presence of Circulating miR-145, miR-155, and miR-382 in Exosomes Isolated from Serum of Breast Cancer Patients and Healthy Donors
    Gonzalez-Villasana, Vianey
    Rashed, Mohammed H.
    Gonzalez-Cantu, Yessica
    Bayraktar, Recep
    Luis Menchaca-Arredondo, Jorge
    Manuel Vazquez-Guillen, Jose
    Rodriguez-Padilla, Cristina
    Lopez-Berestein, Gabriel
    Resendez-Perez, Diana
    DISEASE MARKERS, 2019, 2019
  • [40] MiR-155 Promotes Uveal Melanoma Cell Proliferation and Invasion by Regulating NDFIP1 Expression
    Peng, Jing
    Liu, Honglei
    Liu, Cuihong
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2017, 16 (06) : 1160 - 1167